CFAP95
gene geneOn this page
Summary
CFAP95 (cilia and flagella associated protein 95, HGNC:31422) is a protein-coding gene on chromosome 9q21.12, encoding Cilia- and flagella-associated protein 95 (Q5VTT2). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule and plasma membrane.
Source: NCBI Gene 138255 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 11 total
- GTEx eGene: eQTL in 10 tissues, sQTL in 4 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.26 (unconstrained)
- MANE Select transcript:
NM_001010940 - Interaction hub: 1,801 STRING partners (top 9% of genes corpus-wide)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31422 |
| Approved symbol | CFAP95 |
| Name | cilia and flagella associated protein 95 |
| Location | 9q21.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204711 |
| Ensembl biotype | protein_coding |
| Entrez | 138255 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 8 protein_coding, 6 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
MANE Select: ENST00000377197
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 5, TSL 2: 1, TSL 5: 1
ENST00000377197, ENST00000466872, ENST00000480564, ENST00000495399, ENST00000527647, ENST00000529131, ENST00000529446, ENST00000936456, ENST00000936457, ENST00000936458, ENST00001060495, ENST00001060496, ENST00001060497, ENST00001060500, ENST00001138511
RefSeq mRNA: 4 — MANE Select: NM_001010940
NM_001010940, NM_001308084, NM_001308085, NM_001308086
CCDS: CCDS35041, CCDS78403
Canonical transcript exons
ENST00000377197 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001473067 | 69905954 | 69906227 |
| ENSE00001473072 | 69844517 | 69844625 |
| ENSE00001473074 | 69820817 | 69821031 |
| ENSE00003515718 | 69856555 | 69856673 |
| ENSE00003528405 | 69886838 | 69886895 |
| ENSE00003639731 | 69857909 | 69857977 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 99.28.
FANTOM5 (CAGE): breadth broad, TPM avg 2.5293 / max 151.9756, expressed in 287 samples.
Highest expression (Bgee): bronchial epithelial cell, bronchus, male germ line stem cell (sensu Vertebrata) in testis, olfactory segment of nasal mucosa, sperm.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP95 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 10 tissues and its splicing (sQTL) in 4 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
14 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Pituitary | eqtl | 1.0e-35 | +0.74 | 9:69803217:C:G |
| Pancreas | eqtl | 1.6e-35 | +1.45 | 9:69820797:C:G |
| Brain Nucleus accumbens basal ganglia | eqtl | 2.2e-17 | +1.04 | 9:69792139:T:C |
| Testis | eqtl | 5.7e-10 | +0.20 | 9:69844651:G:T |
| Testis | sqtl | 6.7e-10 | -0.45 | 9:69844651:G:T |
| Pituitary | sqtl | 7.2e-10 | -0.86 | 9:69844651:G:T |
| Brain Putamen basal ganglia | eqtl | 2.2e-04 | -0.44 | 9:69883553:C:T |
| Kidney Cortex | eqtl | 3.4e-04 | +1.36 | 9:69792139:T:C |
| Brain Anterior cingulate cortex BA24 | eqtl | 1.7e-03 | +0.63 | 9:69829308:T:C |
| Muscle Skeletal | eqtl | 3.3e-03 | +0.16 | 9:69873501:C:T |
| Brain Amygdala | eqtl | 6.5e-03 | +0.59 | 9:69792139:T:C |
| Brain Nucleus accumbens basal ganglia | sqtl | 2.1e-02 | -0.65 | 9:69818165:G:A |
| Lung | sqtl | 2.3e-02 | -0.43 | 9:69868731:A:G |
| Lung | eqtl | 2.7e-02 | -0.13 | 9:69823644:C:T |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96847 | 1.6418 | 265 |
| 96848 | 0.8875 | 115 |
Top tissues by expression
showing 100 of 239 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.28 | gold quality |
| bronchus | UBERON:0002185 | 98.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.84 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.04 | gold quality |
| sperm | CL:0000019 | 92.87 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.60 | gold quality |
| right uterine tube | UBERON:0001302 | 92.09 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 90.14 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.26 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.21 | gold quality |
| pituitary gland | UBERON:0000007 | 85.47 | gold quality |
| trachea | UBERON:0003126 | 84.41 | gold quality |
| fallopian tube | UBERON:0003889 | 83.62 | gold quality |
| left testis | UBERON:0004533 | 83.33 | gold quality |
| right testis | UBERON:0004534 | 82.68 | gold quality |
| adenohypophysis | UBERON:0002196 | 82.49 | gold quality |
| testis | UBERON:0000473 | 81.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.54 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 80.39 | gold quality |
| caput epididymis | UBERON:0004358 | 79.08 | gold quality |
| body of tongue | UBERON:0011876 | 78.23 | gold quality |
| secondary oocyte | CL:0000655 | 77.48 | gold quality |
| adult organism | UBERON:0007023 | 76.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 73.56 | silver quality |
| biceps brachii | UBERON:0001507 | 72.01 | gold quality |
| right lung | UBERON:0002167 | 70.26 | gold quality |
| tongue | UBERON:0001723 | 67.37 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 66.16 | gold quality |
| endometrium | UBERON:0001295 | 65.27 | gold quality |
| hypothalamus | UBERON:0001898 | 65.14 | gold quality |
| deltoid | UBERON:0001476 | 64.92 | gold quality |
| amygdala | UBERON:0001876 | 62.96 | gold quality |
| oocyte | CL:0000023 | 62.29 | gold quality |
| superior surface of tongue | UBERON:0007371 | 61.66 | gold quality |
| left uterine tube | UBERON:0001303 | 61.61 | gold quality |
| pancreas | UBERON:0001264 | 61.35 | gold quality |
| gall bladder | UBERON:0002110 | 60.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.15 | gold quality |
| caudate nucleus | UBERON:0001873 | 59.05 | gold quality |
| quadriceps femoris | UBERON:0001377 | 58.92 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 58.50 | gold quality |
| lower lobe of lung | UBERON:0008949 | 58.16 | silver quality |
| Ammon’s horn | UBERON:0001954 | 58.00 | gold quality |
| metanephros cortex | UBERON:0010533 | 57.66 | gold quality |
| vastus lateralis | UBERON:0001379 | 57.47 | silver quality |
| corpus callosum | UBERON:0002336 | 56.96 | gold quality |
| kidney epithelium | UBERON:0004819 | 56.66 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 56.58 | gold quality |
| lung | UBERON:0002048 | 56.15 | gold quality |
| pancreatic ductal cell | CL:0002079 | 55.18 | silver quality |
| substantia nigra | UBERON:0002038 | 54.84 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 54.73 | gold quality |
| tibialis anterior | UBERON:0001385 | 54.71 | silver quality |
| nucleus accumbens | UBERON:0001882 | 54.67 | gold quality |
| amniotic fluid | UBERON:0000173 | 54.64 | silver quality |
| muscle tissue | UBERON:0002385 | 54.35 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.06 | gold quality |
| temporal lobe | UBERON:0001871 | 53.97 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| cerebellar vermis | UBERON:0004720 | 53.12 | gold quality |
| midbrain | UBERON:0001891 | 53.10 | gold quality |
| ileal mucosa | UBERON:0000331 | 53.09 | silver quality |
| metanephros | UBERON:0000081 | 53.03 | gold quality |
| upper lobe of lung | UBERON:0008948 | 53.02 | gold quality |
| kidney | UBERON:0002113 | 52.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 52.90 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 52.72 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 52.68 | gold quality |
| body of pancreas | UBERON:0001150 | 52.65 | gold quality |
| forebrain | UBERON:0001890 | 52.43 | gold quality |
| spinal cord | UBERON:0002240 | 52.02 | gold quality |
| muscle of leg | UBERON:0001383 | 52.01 | gold quality |
| apex of heart | UBERON:0002098 | 51.41 | gold quality |
| endocervix | UBERON:0000458 | 51.08 | gold quality |
| gastrocnemius | UBERON:0001388 | 50.72 | gold quality |
| rectum | UBERON:0001052 | 50.59 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| brain | UBERON:0000955 | 49.79 | gold quality |
| uterus | UBERON:0000995 | 49.68 | gold quality |
| corpus epididymis | UBERON:0004359 | 48.50 | gold quality |
| putamen | UBERON:0001874 | 47.40 | gold quality |
| cortex of kidney | UBERON:0001225 | 47.24 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 46.39 | gold quality |
| thymus | UBERON:0002370 | 45.73 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 45.50 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 45.43 | gold quality |
| cerebral cortex | UBERON:0000956 | 45.37 | gold quality |
| heart left ventricle | UBERON:0002084 | 45.21 | gold quality |
| cardiac ventricle | UBERON:0002082 | 45.13 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 44.83 | gold quality |
| medulla oblongata | UBERON:0001896 | 44.79 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 44.56 | silver quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 44.43 | gold quality |
| heart right ventricle | UBERON:0002080 | 44.34 | gold quality |
| renal medulla | UBERON:0000362 | 44.16 | silver quality |
| germinal epithelium of ovary | UBERON:0001304 | 44.00 | silver quality |
| jejunum | UBERON:0002115 | 43.48 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 61.83 |
| E-HCAD-1 | yes | 26.59 |
| E-MTAB-10287 | yes | 25.96 |
| E-MTAB-9388 | yes | 11.40 |
| E-MTAB-6524 | no | 70.50 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Tissue enhanced
48 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Fallopian tube | tissue | 34.6 |
| Periaqueductal gray | tissue | 19.0 |
| Choroid plexus | tissue | 13.8 |
| Testis | tissue | 13.3 |
| Medulla oblongata | tissue | 12.7 |
| Spinal cord | tissue | 12.2 |
| Basal ganglia | tissue | 12.0 |
| Hippocampal formation | tissue | 11.9 |
| Substantia nigra | tissue | 11.8 |
| Septum | tissue | 11.7 |
| Corpus callosum | tissue | 10.9 |
| Hypothalamus | tissue | 10.4 |
| Pons | tissue | 10.3 |
| Midbrain | tissue | 10.2 |
| Superior colliculi | tissue | 9.8 |
| Thalamus | tissue | 9.7 |
| Ventral forebrain | tissue | 9.2 |
| Cerebral cortex | tissue | 8.9 |
| Occipital cortex | tissue | 8.9 |
| Putamen | tissue | 8.7 |
| Amygdala | tissue | 8.1 |
| Prefrontal cortex | tissue | 7.7 |
| Motor cortex | tissue | 7.7 |
| Entorhinal cortex | tissue | 7.6 |
| Somatosensory cortex | tissue | 7.6 |
| Temporal cortex | tissue | 7.4 |
| Pituitary gland | tissue | 7.2 |
| Retrosplenial and cingulate cortex | tissue | 7.0 |
| Retrosplenial cortex | tissue | 6.7 |
| Olfactory bulb | tissue | 6.3 |
| Insular cortex | tissue | 6.1 |
| Cerebellum | tissue | 4.1 |
| Parathyroid gland | tissue | 2.8 |
| Caudate putamen | tissue | 2.8 |
| Lung | tissue | 2.1 |
| Frontal cortex | tissue | 1.8 |
| Gallbladder | tissue | 1.3 |
| Kidney | tissue | 1.2 |
| Cervix | tissue | 0.8 |
| Locus coeruleus | tissue | 0.8 |
| Retina | tissue | 0.6 |
| Pancreas | tissue | 0.5 |
| Endometrium 1 | tissue | 0.5 |
| Nucleus accumbens | tissue | 0.4 |
| Adrenal gland | tissue | 0.4 |
| Seminal vesicle | tissue | 0.3 |
| Hippocampus | tissue | 0.3 |
| Thymus | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 98; highest nTPM — Dorsal spinal cord (12.2), Ventral spinal cord (12.2), Dorsal hippocampus (11.9), White matter (10.9), Ventral hippocampus (10.4).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 0.00079, LOEUF 1.26, missense Z -0.173 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000377197 — one region, missense o/e 1.08.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cfap95 | ENSMUSG00000033053 |
| rattus_norvegicus | Cfap95 | ENSRNOG00000036615 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q32L77 | 78.6% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| SMC5-DT | ncRNA | 100507299 |
| MAMDC2 | protein-coding | 256691 |
| APBA1 | protein-coding | 320 |
| PTAR1 | protein-coding | 375743 |
| CFAP95-DT | ncRNA | 494558 |
| MAMDC2-AS1 | ncRNA | 100507244 |
| SMC5 | protein-coding | 23137 |
| KLF9 | protein-coding | 687 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 95 — Q5VTT2 (reviewed: Q5VTT2)
All UniProt accessions (4): Q5VTT2, E9PIA3, H0YD79, H0YDM9
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with MYH9. Interacts with MYH10.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme. Cell membrane.
Tissue specificity. Expressed in undifferentiated embryonic stem cells. Expressed in airway epithelial cells.
Induction. Down-regulated following embryonic stem cells differentiation.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VTT2-1 | 1 | yes |
| Q5VTT2-2 | 2 |
RefSeq proteins (4): NP_001010940, NP_001295013, NP_001295014, NP_001295015 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027905 | CFAP95 | Family |
Pfam: PF15139
UniProt features (7 total): topological domain 2, chain 1, transmembrane region 1, region of interest 1, glycosylation site 1, splice variant 1
Structure
Experimental structures (PDB)
2 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 7UNG | 48-nm repeat of the human respiratory doublet microtubule | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | 96nm repeat of human respiratory doublet microtubule and associated axonemal complexes | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VTT2-F1 | 63.03 | 0.00 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mid piece; principal piece
Antibody reliability (HPA): IH uncertain · IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1)
| Type | Positions |
|---|---|
| N-linked (glcnac…) asparagine | 75 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 54 (showing top):
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CYTOPLASMIC_MICROTUBULE, GOCC_CILIUM, chr9q21, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, RAO_BOUND_BY_SALL4_ISOFORM_B, GOCC_AXONEMAL_MICROTUBULE, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER
GO Biological Process (1): flagellated sperm motility (GO:0030317)
GO Cellular Component (6): cytoplasm (GO:0005737), axonemal microtubule (GO:0005879), plasma membrane (GO:0005886), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), axoneme (GO:0005930)
GO top-level categories
15 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| intracellular anatomical structure | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| membrane | 1 |
| cell periphery | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 7 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| axonemal microtubule | CC | direct assay |
| cytoplasm | CC | direct assay |
| plasma membrane | CC | direct assay |
Protein interactions and networks
STRING
showing 16 of 1,801 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP95 | FAM219A | Q8IW50 | 390 |
| CFAP95 | SHC2 | P98077 | 369 |
| CFAP95 | MORN5 | Q5VZ52 | 364 |
| CFAP95 | DRICH1 | Q6PGQ1 | 361 |
| CFAP95 | TPRG1 | Q6ZUI0 | 353 |
| CFAP95 | PADI1 | Q9ULC6 | 346 |
| CFAP95 | PPDPFL | Q8WWR9 | 323 |
| CFAP95 | FHIP2A | Q5W0V3 | 315 |
| CFAP95 | RSPH14 | Q9UHP6 | 303 |
| CFAP95 | HDDC2 | Q7Z4H3 | 293 |
| CFAP95 | IGSF3 | O75054 | 287 |
| CFAP95 | GANC | Q8TET4 | 285 |
| CFAP95 | DPCD | Q9BVM2 | 280 |
| CFAP95 | GPR176 | Q14439 | 280 |
| CFAP95 | LRCH2 | Q5VUJ6 | 275 |
| CFAP95 | ODF4 | Q2M2E3 | 275 |
IntAct
Human interaction partners of CFAP95 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
1 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| PB2 | physical association | 0.370 | 1 |
Disease & clinical
Genetic variants
Variant evidence for CFAP95: 11 ClinVar records (0 pathogenic / likely pathogenic); 5 GWAS associations.
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 1 |
| Benign | 2 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 36 predictions of 721):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 9:69844515 | acceptor_gain | 1.0000 | |
| 9:69821032–69821033 | donor_loss | 0.9900 | 5 |
| 9:69844516 | acceptor_gain | 0.9900 | |
| 9:69844626–69844630 | donor_loss | 0.9900 | 10 |
| 9:69886896–69886897 | donor_loss | 0.9900 | 5 |
| 9:69886900 | donor_loss | 0.9900 | 2 |
| 9:69905952–69905953 | acceptor_loss | 0.9900 | 6 |
| 9:69830098 | acceptor_gain | 0.9800 | |
| 9:69844515–69844516 | acceptor_loss | 0.9800 | 4 |
| 9:69844628 | donor_loss | 0.9800 |
AlphaMissense
170 missense substitutions predicted likely pathogenic (of 1,502 scored), across 64 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F188 | 7 | 0.886 | 0.969 |
| W202 | 7 | 0.842 | 0.935 |
| W51 | 7 | 0.782 | 0.868 |
| D190 | 6 | 0.686 | 0.751 |
| Y42 | 5 | 0.797 | 0.872 |
| R182 | 5 | 0.791 | 0.894 |
| K183 | 5 | 0.743 | 0.833 |
| G207 | 5 | 0.706 | 0.790 |
| S206 | 4 | 0.830 | 0.891 |
| K195 | 4 | 0.759 | 0.838 |
| G31 | 4 | 0.726 | 0.866 |
| K215 | 4 | 0.726 | 0.835 |
| C184 | 4 | 0.685 | 0.738 |
| D204 | 4 | 0.669 | 0.709 |
| W89 | 4 | 0.646 | 0.683 |
| F136 | 3 | 0.867 | 0.867 |
| F58 | 3 | 0.844 | 0.844 |
| K60 | 3 | 0.780 | 0.804 |
| N200 | 3 | 0.779 | 0.832 |
| S186 | 3 | 0.768 | 0.839 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Lung Adenocarcinoma, Testicular Germ Cell Tumor)
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
5 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST005580_291 | Intraocular pressure | 1e-11 |
| GCST005580_133 | Intraocular pressure | 2e-10 |
| GCST009310_1 | Sensorimotor dexterity | 4e-8 |
| GCST011176_10 | Stroke | 2e-7 |
| GCST009208_5 | Transverse temporal cortex volume | 4e-6 |
EFO canonical traits (from GWAS)
2 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004695 | intraocular pressure measurement |
| EFO:0008354 | cognitive function measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 8 |
| entinostat | increases expression, affects cotreatment | 2 |
| methylmercuric chloride | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Vorinostat | affects cotreatment, increases expression | 1 |
| Panobinostat | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.